0
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ciência e resistência: a contribuição da comunidade acadêmica para a luta indígena no Supremo Tribunal Federal Translated title: Science and resistance: the contribution of the academic community to the indigenous struggle in the Federal Supreme Court Translated title: Ciencia y resistencia: la contribución de la comunidad académica a la lucha indígena en la Corte Suprema

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumo: Esta nota de conjuntura tem como objetivo registrar historicamente o contexto de proposição da Arguição de Descumprimento de Preceito Fundamental 709, primeira ação no âmbito do Supremo Tribunal Federal protagonizada por uma organização indígena, a Articulação dos Povos Indígenas do Brasil, na conjuntura da pandemia da covid-19. Apresentamos neste texto a mobilização de grupos de pesquisadores da área de saúde indígena articulados com lideranças e movimentos indígenas que denunciaram a vulnerabilidade e os graves impactos da covid-19 para os povos indígenas e as fragilidades da resposta do governo federal. Destacamos a atuação dos pesquisadores do Grupo Temático de Saúde Indígena da Associação Brasileira de Saúde Coletiva e da Fundação Oswaldo Cruz, que constituíram um grupo de especialistas para apoiar as decisões do ministro Luís Roberto Barroso no âmbito da Arguição de Descumprimento de Preceito Fundamental 709. Sintetizamos o vasto registro processual da proposição desta arguição de descumprimento, a qual apresenta um conjunto de evidências sobre as fragilidades do planejamento e da resposta governamental durante o período crítico da pandemia. Em um contexto de crise sanitária e violação de direitos, o movimento indígena valorizou a ciência e foi capaz de potencializar a incidência dos pesquisadores para sua resistência e luta pelo direito à saúde.

          Translated abstract

          ABSTRACT This conjuncture note aims to record historically the context of proposition of the Argument of Noncompliance with Fundamental Precept 709, the first action within the scope of the Federal Supreme Court led by an indigenous organization, the Articulation of Indigenous Peoples of Brazil, in the context of the COVID-19 pandemic. In this text, we present the mobilization of groups of researchers in indigenous health articulated with indigenous leaderships and indigenous movements who denounced the vulnerability and severe impacts of COVID-19 on indigenous peoples and the weaknesses of the federal government’s response. We highlight the work of researchers from the Indigenous Health Thematic Group of the Brazilian Association of Collective Health and the Fundação Oswaldo Cruz, who constituted a group of experts to support the decisions of Minister Luís Roberto Barroso within the scope of the Argument of Noncompliance with Fundamental Precept 709. We summarize the vast procedural record of the proposition of this non-compliance allegation, which presents evidence on the weaknesses of government planning and response during the critical period of the pandemic. In a context of health crisis and violation of rights, the indigenous movement valued science and enhanced the incidence of researchers for their resistance and struggle for the right to health.

          Translated abstract

          Resumen Esta nota de conyuntura tiene como objetivo registrar históricamente el contexto en el que se presentó el Argumento de Incumplimiento del Precepto Fundamental 709, la primera acción ante el Tribunal Supremo por una organización indígena, la Articulación de los Pueblos Indígenas de Brasil, en el contexto de la pandemia del Covid-19. En este texto, presentamos la movilización de los grupos de investigadores en el campo de la salud indígena, en conjunto con las liderazgos y movimentos indígenas, que han denunciado la vulnerabilidad y los graves impactos del Covid-19 en los pueblos indígenas y las debilidades de la respuesta del gobierno federal. Destacamos el trabajo de los investigadores del Grupo Temático de Salud Indígena de la Asociación Brasileña de Salud Colectiva y de la Fundação Oswaldo Cruz, que formaron un grupo de expertos para apoyar las decisiones del juez Luís Roberto Barroso en el contexto de la Demanda de Incumplimiento del Precepto Fundamental 709. Recopilamos el amplio registro procesal de la moción de declaración de incumplimiento, que presenta un conjunto de pruebas sobre las debilidades de la planificación y la respuesta del gobierno durante el período crítico de la pandemia. En un contexto de crisis sanitaria y violación de derechos, el movimiento indígena valoró la ciencia y supo aprovechar la influencia de los investigadores en su resistencia y lucha por el derecho a la salud.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Indigenous and tribal peoples' health (The Lancet-Lowitja Institute Global Collaboration): a population study.

          International studies of the health of Indigenous and tribal peoples provide important public health insights. Reliable data are required for the development of policy and health services. Previous studies document poorer outcomes for Indigenous peoples compared with benchmark populations, but have been restricted in their coverage of countries or the range of health indicators. Our objective is to describe the health and social status of Indigenous and tribal peoples relative to benchmark populations from a sample of countries.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

            Background Most low-income and middle-income countries (LMICs) have little or no data integrated into a national surveillance system to identify characteristics or outcomes of COVID-19 hospital admissions and the impact of the COVID-19 pandemic on their national health systems. We aimed to analyse characteristics of patients admitted to hospital with COVID-19 in Brazil, and to examine the impact of COVID-19 on health-care resources and in-hospital mortality. Methods We did a retrospective analysis of all patients aged 20 years or older with quantitative RT-PCR (RT-qPCR)-confirmed COVID-19 who were admitted to hospital and registered in SIVEP-Gripe, a nationwide surveillance database in Brazil, between Feb 16 and Aug 15, 2020 (epidemiological weeks 8–33). We also examined the progression of the COVID-19 pandemic across three 4-week periods within this timeframe (epidemiological weeks 8–12, 19–22, and 27–30). The primary outcome was in-hospital mortality. We compared the regional burden of hospital admissions stratified by age, intensive care unit (ICU) admission, and respiratory support. We analysed data from the whole country and its five regions: North, Northeast, Central-West, Southeast, and South. Findings Between Feb 16 and Aug 15, 2020, 254 288 patients with RT-qPCR-confirmed COVID-19 were admitted to hospital and registered in SIVEP-Gripe. The mean age of patients was 60 (SD 17) years, 119 657 (47%) of 254 288 were aged younger than 60 years, 143 521 (56%) of 254 243 were male, and 14 979 (16%) of 90 829 had no comorbidities. Case numbers increased across the three 4-week periods studied: by epidemiological weeks 19–22, cases were concentrated in the North, Northeast, and Southeast; by weeks 27–30, cases had spread to the Central-West and South regions. 232 036 (91%) of 254 288 patients had a defined hospital outcome when the data were exported; in-hospital mortality was 38% (87 515 of 232 036 patients) overall, 59% (47 002 of 79 687) among patients admitted to the ICU, and 80% (36 046 of 45 205) among those who were mechanically ventilated. The overall burden of ICU admissions per ICU beds was more pronounced in the North, Southeast, and Northeast, than in the Central-West and South. In the Northeast, 1545 (16%) of 9960 patients received invasive mechanical ventilation outside the ICU compared with 431 (8%) of 5388 in the South. In-hospital mortality among patients younger than 60 years was 31% (4204 of 13 468) in the Northeast versus 15% (1694 of 11 196) in the South. Interpretation We observed a widespread distribution of COVID-19 across all regions in Brazil, resulting in a high overall disease burden. In-hospital mortality was high, even in patients younger than 60 years, and worsened by existing regional disparities within the health system. The COVID-19 pandemic highlights the need to improve access to high-quality care for critically ill patients admitted to hospital with COVID-19, particularly in LMICs. Funding National Council for Scientific and Technological Development (CNPq), Coordinating Agency for Advanced Training of Graduate Personnel (CAPES), Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ), and Instituto de Salud Carlos III.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys

              Background Population-based data on COVID-19 are essential for guiding policies. There are few such studies, particularly from low or middle-income countries. Brazil is currently a hotspot for COVID-19 globally. We aimed to investigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence by city and according to sex, age, ethnicity group, and socioeconomic status, and compare seroprevalence estimates with official statistics on deaths and cases. Methods In this repeated cross-sectional study, we did two seroprevalence surveys in 133 sentinel cities in all Brazilian states. We randomly selected households and randomly selected one individual from all household members. We excluded children younger than 1 year. Presence of antibodies against SARS-CoV-2 was assessed using a lateral flow point-of-care test, the WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech, Guangzhou, China), using two drops of blood from finger prick samples. This lateral-flow assay detects IgG and IgM isotypes that are specific to the SARS-CoV-2 receptor binding domain of the spike protein. Participants also answered short questionnaires on sociodemographic information (sex, age, education, ethnicity, household size, and household assets) and compliance with physical distancing measures. Findings We included 25 025 participants in the first survey (May 14–21) and 31 165 in the second (June 4–7). For the 83 (62%) cities with sample sizes of more than 200 participants in both surveys, the pooled seroprevalence increased from 1·9% (95% CI 1·7–2·1) to 3·1% (2·8–3·4). City-level prevalence ranged from 0% to 25·4% in both surveys. 11 (69%) of 16 cities with prevalence above 2·0% in the first survey were located in a stretch along a 2000 km of the Amazon river in the northern region. In the second survey, we found 34 cities with prevalence above 2·0%, which included the same 11 Amazon cities plus 14 from the northeast region, where prevalence was increasing rapidly. Prevalence levels were lower in the south and centre-west, and intermediate in the southeast, where the highest level was found in Rio de Janeiro (7·5% [4·2–12·2]). In the second survey, prevalence was similar in men and women, but an increased prevalence was observed in participants aged 20–59 years and those living in crowded conditions (4·4% [3·5–5·6] for those living with households with six or more people). Prevalence among Indigenous people was 6·4% (4·1–9·4) compared with 1·4% (1·2–1·7) among White people. Prevalence in the poorest socioeconomic quintile was 3·7% (3·2–4·3) compared with 1·7% (1·4–2·2) in the wealthiest quintile. Interpretation Antibody prevalence was highly heterogeneous by country region, with rapid initial escalation in Brazil's north and northeast. Prevalence is strongly associated with Indigenous ancestry and low socioeconomic status. These population subgroups are unlikely to be protected if the policy response to the pandemic by the national government continues to downplay scientific evidence. Funding Brazilian Ministry of Health, Instituto Serrapilheira, Brazilian Collective Health Association, and the JBS Fazer o Bem Faz Bem.
                Bookmark

                Author and article information

                Journal
                tes
                Trabalho, Educação e Saúde
                Trab. educ. saúde
                Fundação Oswaldo Cruz, Escola Politécnica de Saúde Joaquim Venâncio (Rio de Janeiro, RJ, Brazil )
                1678-1007
                1981-7746
                2024
                : 22
                : e026397246
                Affiliations
                [1] orgnameFundação Oswaldo Cruz orgdiv1Escola Nacional de Saúde Pública Sergio Arouca orgdiv2Departamento de Endemias Samuel Pessoa Brazil
                [2] orgnameFundação Oswaldo Cruz orgdiv1Escola Nacional de Saúde Pública Sergio Arouca orgdiv2Departamento de Endemias Samuel Pessoa Brazil
                Author information
                https://orcid.org/0000-0001-9162-5345
                https://orcid.org/0000-0002-5028-8888
                Article
                S1981-77462024000100300 S1981-7746(24)02200000300
                10.1590/1981-7746-ojs2697
                cc8dfa75-b410-41f5-a985-084da4fca3dc

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 13 December 2023
                : 07 March 2024
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 44, Pages: 0
                Product

                SciELO Brazil


                judicialização da saúde,participación social,Covid-19,pueblos indígenas,salud indígena,judicialización de la salud,social participation,covid-19,indigenous peoples,indigenous health,judicialization of health,participação social,povos indígenas,saúde indígena

                Comments

                Comment on this article